Skip to content

Clinical trials

Phase 4 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 4 Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20052
20063
20074
20086
20104
20114
20127
20131
20142
20154
20162
20174
20181
20191
20212
20222
20233
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated14
Withdrawn6
Unknown status6
Recruiting5
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion11
United Therapeutics11
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Amsterdam UMC, location VUmc3
Brigham and Women's Hospital2
GlaxoSmithKline2
Jewish General Hospital2
Rabin Medical Center2
AOP Orphan Pharmaceuticals AG1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension63
Hypertension, Pulmonary14
Heart Failure3
Idiopathic Pulmonary Fibrosis2
Lung Diseases, Interstitial2
Cardiovascular Diseases1
Connective Tissue Diseases1
Dyspnea1
Eisenmenger Complex1
Familial Primary Pulmonary Hypertension1

Trials

Showing 26 to 50 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.